|
Subgroup analyses for patients and physicians assessments (mean changes of outcome parameters after 24 months compared to baseline, negative Δ indicates improvement) |
||||||
| Patients assessments (NRS) |
Physicians assessments (NRS) |
|||||
| Mean† |
95%-CI |
p value* |
Mean† |
95%-CI |
p value* |
|
|
|
||||||
| Total (n = 3981) |
-3.3 |
-3.4 to -3.2 |
-3.9 |
-4.0 to -3.8 |
0,060 |
|
| Gender |
||||||
| Female (n = 2560) |
-3.4 |
-3.5 to -3.2 |
-3.9 |
-4.0 to -3.8 |
||
| Male (n = 1412) |
-3.3 |
-3.4 to -3.1 |
0.387 |
-3.9 |
-4.0 to -3.8 |
0,060 |
| Age groups (years) |
||||||
| <10 (n = 839) |
-4.0 |
-4.2 to -3.8 |
-4.4 |
-4.6 to -4.2 |
||
| 10–19 (n = 355) |
-3.5 |
-3.7 to -3.2 |
<0.001 |
-4.3 |
-4.5 to -4.0 |
0.149 |
| 20–39 (n = 1456) |
-3.4 |
-3.6 to -3.3 |
<0.001 |
-3.7 |
-3.8 to -3.6 |
<0.001 |
| 40–59 (n = 1041) |
-2.8 |
-3.8 to -2.0 |
<0.001 |
-3.6 |
-3.8 to -3.5 |
<0.001 |
| ≥ 60 (n = 281) |
-2.6 |
-2.9 to -2.2 |
<0.001 |
-3.5 |
-3.8 to -3.2 |
<0.001 |
| Baseline severity of disease |
||||||
| NRS < 6.0 (n = 1660) |
-2.1 |
-2.3 to -2.0 |
-3.1 |
-3.2 to -3.0 |
||
| NRS ≥ 6.0 (n = 2310) |
-4.1 |
-4.2 to -4.0 |
<0.001 |
-4.6 |
-4.7 to -4.5 |
<0.001 |
| Duration of disease in adults (years) |
||||||
| < 10 (n = 1878) |
-3.2 |
-3.4 to -3.1 |
-3.7 |
-3.8 to -3.6 |
||
| ≥ 10 (n = 927) |
-2.9 |
-3.1 to -2.7 |
<0.001 |
-3.6 |
-3.7 to -3.4 |
0.043 |
| Intake of conventional drugs at baseline |
||||||
| Yes (n = 1788) |
-3.3 |
-3.5 to -3.2 |
-3.8 |
-3.9 to -3.7 |
||
| No (n = 2188) |
-3.3 |
-3.5 to -3.2 |
0.157 |
-3.9 |
-4.0 to -3.9 |
0.029 |
| Belief in homeopathy |
||||||
| Strong (n = 2656) |
-3.4 |
-3.5 to -3.1 |
-3.9 |
-4.0 to -3.8 |
||
| Weak (n = 1316) |
-3.1 |
-3.3 to -3.0 |
<0.001 |
-3.8 |
-3.9 to -3.7 |
0.563 |
|
† estimations are based on generalised linear models, NRS = numeric rating scale; * per item each subgroup compared to the first listed subgroup | ||||||
Witt et al. BMC Public Health 2005 5:115 doi:10.1186/1471-2458-5-115 |
||||||